[COMPLARATIVE CHARACTERISTICS OF THE CLINICAL EFFECTS OF TRANQUILIZERS].
D000873:Anthracenes / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008433:Mathematics; D008620:Meprobamate / Q000627:therapeutic use*; D009025:Morpholines / Q000627:therapeutic use*; D009497:Neurotic Disorders / Q000188:drug therapy*; D009567:Nitrazepam / Q000627:therapeutic use*; D010076:Oxazepam / Q000627:therapeutic use*; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000873:Anthracenes; D014151:Anti-Anxiety Agents; D001565:Benzoates; D001570:Benzodiazepinones; D002722:Chlorobenzenes; D009025:Morpholines; D014149:Tranquilizing Agents; D010076:Oxazepam; D002707:Chlordiazepoxide; D009567:Nitrazepam; D008620:Meprobamate; D003975:Diazepam
Sravnitel'naia kharakteristika klinicheskogo desistviia trankvilizatorov